marcus evans europe conferences

4th Edition IDMP Compliance Challenge: Navigating through uncertainty

Benchmark preparations for IDMP compliance and work towards effective data management while breaking silos between divisions

27-29 March 2017
London, United Kingdom


Why You Should Attend

4th Edition IDMP Compliance Challenge: Navigating through uncertainty

Identification of Medicinal Products (IDMP) is one the biggest regulatory challenges for all pharma companies in Europe. The latest regulatory update has defined IDMP compliance as a phased approach with a preparation phase between now and the end of June 2016, followed by a transition phase. The 1st iteration will be focusing on product and substance information, with further standards to come.

This marcus evans conference will focus on IDMP compliance preparations benchmarking and knowledge-sharing for the phased approach deadlines in the context uncertainty and expectations for the final guidelines.

 Despite the fact the implementation guidelines have not been published yet, decisions about the compliance preparations need to be already made today as this legislation has major implications for all companies active in the industry and this means a lot of work to be done in an a very short timeframe, at the same time advanced companies are working on wider business benefits to be realised from data and systems standardisation project.

 This marcus evans conference will focus on gathering corporate professionals from Regulatory Operations, Regulatory Affairs, Master Data Management, Regulatory Information Systems and other key stakeholder departments progressing on IDMP projects in the uncertainty context with already some lessons learnt and practices to share for those who are less advanced in the journey.

Join this practitioner IDMP knowledge exchange platform to discuss latest regulatory developments from EMA, FDA developments on GINAS and hear a number of case studies on IDMP projects, technology selection, preparations for the first iteration, practical experiences on unstructured information and other key areas compliance requirements preparations.

 


Key Topics

  • Benchmark with practitioners ahead of the curve
  • Manage effective compliance work and IDMP strategy despite missing EMA guidelines
  • Focusing on the 1st iteration in practice
  • Preparing for 2nd and further iterations
  • Discussing XEVMPD to IDMP: Data migration questions
  • Previous Attendees Include

    Abbott Laboratories GmbH ∙ Allerghan ∙ Allergopharma GmbH & Co. KG ∙ ArisGlobal GmbH ∙ Aspen Pharma Trading Ltd ∙ Astellas ∙ Bayer Pharma AG ∙ BioMarin Pharmaceutical Inc ∙ Boehringer Ingelheim Pharma GmbH & Co ∙ Celgene Europe Limited ∙ Chiesi Farmaceutici SpA ∙ e-DRA Harmsen ∙ Ernst & Young AG ∙ F.Hoffmann-La Roche Ltd ∙ Ferring International Center SA ∙ Fresenius Kabi Deutschland GmbH ∙ Fresenius Netcare GmbH ∙ Gartner Inc ∙ Genpact Pharmalink ∙ Grunenthal GmbH ∙ Guerbet ∙ HAL Allergy ∙ HighPoint Solutions LLC ∙ i4i Inc ∙ Informatica Corporation ∙ Infotehna ∙ IT-Consulting Life Science ∙ Janssen Pharmaceutical ∙ Johnson & Johnson ∙ Kinapse ∙ LEO Pharma A/S ∙ Marr Consultancy Ltd ∙ Merck Sharp & Dohme ∙ Mesa Arch Consulting ∙ mibe GmbH Arzneimittel ∙ NNIT ∙ Norgine ∙ Novartis Pharma AG ∙ Oracle ∙ Orion Pharma ∙ PAREXEL ∙ Pfizer Incorporated ∙ Pierre Fabre Laboratories ∙ Reckitt Brnckiser Pharmaceuticals ∙ Roche ∙ Sanofi Pasteur MSD – SNC ∙ SAS Institute A/S ∙Shire International GmbH ∙ Stada Arzneimittel AG ∙ Stallergenes SA ∙ Takeda Pharma A/S ∙ Teelia EU ∙ Teva Pharmaceuticals ∙ UCB Biopharma SPRL ∙ Xendo Deutschland GbmH


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.







    Voice of Our Customers
    • “Very fruitful conference, excellent presenters. Thank you.” IDMP Project Lead Novartis Pharma AG
    • “Great job!” Research Director Gartner
    • “Very targeted and productive event. Topic is timely and current.” VP, Life Sciences R&D Practice, HighPoint Solutions
    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Yiota Andreou


    marcus evans (Europe) Ltd
    PO Box 24797
    Cyprus

    Telephone:
    +357 22 849 404
    Fax: +357 22 849 310
    Email: YiotaA@marcusevanscy.com